4219.0: Tuesday, December 13, 2005 - 2:45 PM
Abstract #122162
Potential Impact of Universal Immunization with a Human-Bovine Pentavalent Vaccine on the Health Care Utilization and Costs Associated with Rotavirus Acute Gastroenteritis
Robbin Itzler, PhD, Senior Health Economist, Health Economics Statistics, Merck Research Laboratories, 3535 General Atomics Court, San Diego, CA 92121, (484) 344-2455, robbin_itzler@merck.com
Learning Objectives: At the conclusion of the session, the participant (learner) in the session will be able to
- Identify the reduction in the health care utilization and costs associated with
vaccination against rotavirus gastroenteritis from the health care system and
societal perspectives.
- Assess the key variables that influence the magnitude of the reduction in the
burden of disease from the health care system and societal perspectives (i.e.
the sensitivity of the cost-effectiveness analysis to key variables).
- Know how to critically evaluate the assumptions in other cost-effectiveness
analyses and judge the robustness of the results based on the evidence for
the assumptions included in the cost-effectiveness models.
Presenting author's disclosure statement:
I wish to disclose that I have NO financial interests or other relationship with the
manufactures of commercial products, suppliers of commercial services or commercial supporters.
Recorded presentation
Vaccine Preventable Disease Epidemiology
The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA